Cardiovascular Disease Prevention
11
5
5
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (11)
Monitoring and Guidance of Physical Activity During the Maintenance Phase of Cardiac Rehabilitation: the Antwerp Activity Index
GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV
Digital Prevention Program With Telephonic Coaching
Assessment and Prediction of Cardiovascular Health and Disease Risk Using Wearable Biometrics.
Akershus Cardiac Examination (ACE) 5 Study
Cardiovascular Health of Transgender Individuals During the Gender-affirming Pathway
Family Matters Intervention
Preventative Screening and Health Coaching in a Food Insecure Population
Real-World Evaluation of a Digitally Enabled Cardiac Rehabilitation Program
Community Pharmacist Intervention to Enhance Adherence in Cardiovascular Drug Initiators
Impact of a Nutritional Supplement on Metabolic Health